Exhibit 8.1
Subsidiaries | Country of Incorporation | Voting Interest |
Subsidiaries of Midatech Pharma PLC | ||
Midatech Pharma (Wales) Limited | England and Wales | 100% |
Midatech Limited | England and Wales | 100% |
Midatech Pharma US Inc. | United States (Delaware) | 100% |
Midatech Pharma Pty Limited | Australia | 100% |
Joint Ventures with Midatech Limited | ||
MidaSol Therapeutics GP (1)(3) | Cayman Islands | 50% |
Syntara LLC (2)(3) | United States (Delaware) | 50% |
Subsidiaries of Midatech Limited | ||
Midatech Pharma Espana SL | Spain | 100% |
Pharmida AG (3) | Switzerland | 100% |
Subsidiaries of Midatech Pharma US Inc. | ||
DARA Therapeutics, Inc. | United States (North Carolina) | 100% |
_______________
(1) Joint venture between Midatech Limited and Aquestive Therapuetics, formerly known as MonoSol.
(2) Joint venture between Midatech Limited and Immunotope Inc. The percentage ownership of the entity is determined by reference to the partnership agreement and varies from time to time depending on capital committed. While 50% is the economic interest, Midatech Limited can currently direct 49% of the voting rights.
(3) Dormant entities.